Patents by Inventor Quinn L. Deveraux

Quinn L. Deveraux has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MONOCLONAL ANTIBODIES AND METHODS OF USE
    Publication number: 20220251230
    Abstract: This disclosure relates to immunogens and monoclonal antibodies useful in the identification and/or treatment of cancer cells, including those of the dog. In one example, chimeric anti-canine CD20 antibodies are provided. The antibodies can be used therapeutically to treat lymphoma in dogs.
    Type: Application
    Filed: March 24, 2022
    Publication date: August 11, 2022
    Inventors: Sarah RUE, Brendan ECKELMAN, Quinn L. DEVERAUX, Marc NASOFF
  • Monoclonal antibodies and methods of use
    Patent number: 11319377
    Abstract: This disclosure relates to immunogens and monoclonal antibodies useful in the identification and/or treatment of cancer cells, including those of the dog. In one example, chimeric anti-canine CD20 antibodies are provided. The antibodies can be used therapeutically to treat lymphoma in dogs.
    Type: Grant
    Filed: August 24, 2017
    Date of Patent: May 3, 2022
    Assignee: ELANCO TIERGESUNDHEIT AG
    Inventors: Sarah Rue, Brendan Eckelman, Quinn L. Deveraux, Marc Nasoff
  • Monoclonal Antibodies and Methods of Use
    Publication number: 20170355775
    Abstract: This disclosure relates to immunogens and monoclonal antibodies useful in the identification and/or treatment of cancer cells, including those of the dog. In one example, chimeric anti-canine CD20 antibodies are provided. The antibodies can be used therapeutically to treat lymphoma in dogs.
    Type: Application
    Filed: August 24, 2017
    Publication date: December 14, 2017
    Inventors: Sarah Rue, Brendan Eckelman, Quinn L. Deveraux, Marc Nasoff
  • Methods and compositions for inducing apoptosis in cancer cells with an anti-DR5 antibody
    Patent number: 8173128
    Abstract: Anti-DR5 antibody agonists, combined with apoptosis-inducing agents, synergistically induce apoptosis in cancer cells.
    Type: Grant
    Filed: December 1, 2006
    Date of Patent: May 8, 2012
    Assignee: IRM LLC
    Inventors: Marc Nasoff, Quinn L. Deveraux, Deborah A. Knee, Pedro Aza-Blanc, Garrett M. Hampton, Klaus Wagner
  • Inhibitor of apoptosis proteins and nucleic acids and methods for making and using them
    Patent number: 8119404
    Abstract: The invention provides polypeptides comprising inhibitor of apoptosis protein (IAP) family members, such as BmIAP initially derived from Bombyx mori BmN cells, and nucleic acids encoding them, and methods for making and using these compositions, including their use for inhibiting apoptosis.
    Type: Grant
    Filed: July 8, 2010
    Date of Patent: February 21, 2012
    Assignee: Sanford-Burnham Medical Research Institute
    Inventors: Qihong Huang, John C. Reed, Bruce D. Hammock, Quinn L. Deveraux, Susumu Maeda, Hiroko Maeda, legal representative
  • INHIBITOR OF APOPTOSIS PROTEINS AND NUCLEIC ACIDS AND METHODS FOR MAKING AND USING THEM
    Publication number: 20100275284
    Abstract: The invention provides polypeptides comprising inhibitor of apoptosis protein (IAP) family members, such as BmIAP initially derived from Bombyx mori BmN cells, and nucleic acids encoding them, and methods for making and using these compositions, including their use for inhibiting apoptosis.
    Type: Application
    Filed: July 8, 2010
    Publication date: October 28, 2010
    Applicants: Burnham Institute for Medical Research, The Regents of the University of California
    Inventors: Qihong Huang, John C. Reed, Bruce D. Hammock, Quinn L. Deveraux, Susumu Maeda, Hiroko Maeda
  • Inhibitor of apoptosis proteins and nucleic acids and methods for making and using them
    Patent number: 7786347
    Abstract: The invention provides polypeptides comprising inhibitor of apoptosis protein (IAP) family members, such as BmIAP initially derived from Bombyx mori BmN cells, and nucleic acids encoding them, and methods for making and using these compositions, including their use for inhibiting apoptosis.
    Type: Grant
    Filed: January 16, 2007
    Date of Patent: August 31, 2010
    Assignee: Burnham Institute for Medical Research
    Inventors: Qihong Huang, John C. Reed, Bruce D. Hammock, Quinn L. Deveraux, Susumu Maeda, Hiroko Maeda, legal representative
  • Methods and compositions for inducing apoptosis in cancer cells
    Patent number: 7229617
    Abstract: Anti-DR4 or Anti-DR5 antibody agonists, combined with apoptosis-inducing agents, synergistically induce apoptosis in cancer cells.
    Type: Grant
    Filed: November 25, 2003
    Date of Patent: June 12, 2007
    Assignee: IRM LLC
    Inventors: Marc Nasoff, Quinn L. Deveraux, Deborah A. Knee, Pedro Aza-Blanc, Garret M. Hampton, Klaus Wagner
  • Inhibitor of apoptosis proteins and nucleic acids and methods for making and using them
    Patent number: 7172880
    Abstract: The invention provides polypeptides comprising inhibitor of apoptosis protein (IAP) family members, such as BmIAP initially derived from Bombyx mori BmN cells, and nucleic acids encoding them, and methods for making and using these compositions, including their use for inhibiting apoptosis.
    Type: Grant
    Filed: January 7, 2002
    Date of Patent: February 6, 2007
    Assignees: The Burnham Institute for Medical Research, The Regents of the University of California
    Inventors: Qihong Huang, John C. Reed, Bruce D. Hammock, Quinn L. Deveraux, Hiroko Maeda, legal representative, Susumu Maeda, deceased
  • Diagnosis and treatment of chemoresistant tumors
    Publication number: 20040101915
    Abstract: This invention provides methods of identifying compounds that selectively target cancer cells that have defects in specific oncogenic pathways.
    Type: Application
    Filed: June 18, 2003
    Publication date: May 27, 2004
    Applicant: IRM LLC, a Delaware Limited Liability Company
    Inventors: Quinn L. Deveraux, Klaus W. Wagner, Garrett M. Hampton
  • Inhibitor of apoptosis proteins and nucleic acids and methods for making and using them
    Publication number: 20030049796
    Abstract: The invention provides polypeptides comprising inhibitor of apoptosis protein (IAP) family members, such as BmIAP initially derived from Bombyx mori BmN cells, and nucleic acids encoding them, and methods for making and using these compositions, including their use for inhibiting apoptosis.
    Type: Application
    Filed: January 7, 2002
    Publication date: March 13, 2003
    Applicant: The Burnham Institute
    Inventors: Qihong Huang, John C. Reed, Bruce D. Hammock, Quinn L. Deveraux, Susumu Maeda, Hiroko Maeda